Gubra And AbbVie - AbbVie and Gubra A/S have entered into a licensing agreement to develop GUB014295, a promising long-acting ...
Ripple (XRP) has made headlines once again, surging 40% on Sunday, March 2, after U.S. President Donald Trump issued an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback